SpyGlass Pharma, Inc. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
SpyGlass Pharma, Inc. (SGP) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$8.37 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-03-26
- SpyGlass Pharma, Inc. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was -$8.37M.
- SpyGlass Pharma, Inc. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was -$6.12M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month |
|---|---|
| 2025-12-31 | -$8.37M 10-K · filed 2026-03-26 |
| 2024-12-31 | -$6.12M 10-K · filed 2026-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |